Form 4 holding
Chief Medical Officer
INOVIO PHARMACEUTICALS, INC.
- Security class
- Common Stock
- Shares / value
- 42,038
- Estimated value
- $73,146
- Report date
- 20 May 2026
- Price
- $1.74
- Ownership
- Direct
Michael John Sumner - Chief Medical Officer at INOVIO PHARMACEUTICALS, INC.
Issuer-level insider activity
- Role
- Chief Medical Officer
- Issuer ticker
- INO on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Michael John Sumner since 11 Aug 2025
Reported holdings for Michael John Sumner in INOVIO PHARMACEUTICALS, INC.
Form 4 holding
Chief Medical Officer
INOVIO PHARMACEUTICALS, INC.
- Security class
- Restricted Stock Unit
- Shares / value
- 37,684
- Estimated value
- $68,607
- Report date
- 20 May 2026
- Price
- $1.98
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Chief Medical Officer
INOVIO PHARMACEUTICALS, INC.
- Security class
- Common Stock Option
- Shares / value
- 46,876
- Estimated value
- Report date
- 20 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Michael John Sumner in INOVIO PHARMACEUTICALS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.